Internal restructuring
Location of affected unit(s)
Temecula (US) and Clonmel (Ireland)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

650 jobs
Number of planned job losses
Job loss
Announcement Date
21 February 2013
Employment effect (start)
21 February 2013
Foreseen end date


Pharmaceutical company Abbott is currently in the process of making 650 of its staff in Ireland and the US redundant. The company, which produces pharmaceuticals, medical and nutritional products, says that these job reduction measures form part of a previously communicated adjustment strategy set out to increase its efficiency.

According to reports, the company has issued redundancy notices at its Temecula plant in California, US, which specializes in vascular devices, affecting 450 of its staff. The job cuts were primarily located in the company’s manufacturing and manufacturing support divisions, affecting full-time employees only. While the Temecula plant continues to employ around 2,000 staff, the plant has witnessed a loss of 1,000 positions since January 2012.

At the same time, the company also intends to eliminate 200 positions in Ireland. The job cuts will be affected at the company’s Clonmel plant, which also specializes in vascular devices and currently employs around 1,400 staff. According to Abbott, these job reduction measures have become necessary due to a downturn in demand for the company’s older products.

According to reports, the company wants to focus on voluntary redundancies and also plans to not renew temporary contracts. Moreover, Abbott remains committed to assist those affected by redundancies and in Ireland a 30-day consultation period with employees has been initiated.

The global healthcare company currently employs around 70,000 employees across 150 countries. American based Abbott has been continuously reducing its staff over the past 3 years (see here).


  • 21 February 2013: The Press Enterprise
  • 21 February 2013: Belfast Telegraph
  • 21 February 2013: FierceMedicalDevices
  • 21 February 2013: Murrieta Patch


Eurofound (2013), Abbott, Internal restructuring in World, factsheet number 74968, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74968.